Profound Medical Corp Stock Analysis

Profound Stock Analysis Notes

About 35.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.32. Profound Medical Corp last dividend was issued on the 16th of October 2019. The entity had 1:10 split on the 16th of October 2019. Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada. Profound Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 146 people. To find out more about Profound Medical Corp contact Arun MBA at 647 476 1350 or learn more at https://www.profoundmedical.com.

Profound Medical Corp Investment Alerts

Profound Medical Corp Upcoming and Recent Events

Profound Largest EPS Surprises

View All Earnings Estimates

Profound Medical Environmental, Social, and Governance (ESG) Scores

Profound Medical Thematic Classifications

Profound Stock Institutional Investors

Note, although Profound Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Profound Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 278 M.

Profound Profitablity

The company has Profit Margin (PM) of (2.75) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.69) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.69.

Management Efficiency

Profound Medical Corp has return on total asset (ROA) of (0.6244) % which means that it has lost $0.6244 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2449) %, meaning that it created substantial loss on money invested by shareholders. Profound Medical's management efficiency ratios could be used to measure how well Profound Medical manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.38. The current Return On Capital Employed is estimated to decrease to -0.49. At this time, Profound Medical's Non Currrent Assets Other are most likely to increase significantly in the upcoming years. The Profound Medical's current Fixed Asset Turnover is estimated to increase to 12.29, while Total Assets are projected to decrease to roughly 49 M.

Technical Drivers

As of the 6th of January, Profound Medical holds the Coefficient Of Variation of 552.12, risk adjusted performance of 0.1394, and Semi Deviation of 2.98. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Profound Medical, as well as the relationship between them. Please check Profound Medical Corp variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Profound Medical Corp is priced some-what accurately, providing market reflects its current price of 7.77 per share. Given that Profound Medical has jensen alpha of 0.5869, we recommend you to check out Profound Medical Corp's recent market performance to make sure the company can sustain itself at a future point.

Profound Medical Corp Price Movement Analysis

Profound Medical Corp Insider Trading Activities

Profound Medical Outstanding Bonds

Profound Medical Predictive Daily Indicators

Profound Medical Corporate Filings

Profound Medical Forecast Models

Profound Medical's time-series forecasting models are one of many Profound Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Profound Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Profound Medical Bond Ratings

Profound Medical Corp financial ratings play a critical role in determining how much Profound Medical have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Profound Medical's borrowing costs.

Profound Medical Corp Debt to Cash Allocation

Profound Medical Corp currently holds 5.12 M in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. Profound Medical Corp has a current ratio of 17.01, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Profound Medical's use of debt, we should always consider it together with its cash and equity.

Profound Medical Total Assets Over Time

Profound Medical Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Profound Medical uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Profound Medical Debt Ratio

7.97

It seems as most of the Profound Medical's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Profound Medical's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Profound Medical, which in turn will lower the firm's financial flexibility.

Profound Medical Corporate Bonds Issued

Profound Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Profound Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Profound shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Profound Medical. By using and applying Profound Stock analysis, traders can create a robust methodology for identifying Profound entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Profound analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Profound analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Profound Medical Corp stock analysis indicators help investors evaluate how Profound Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Profound Medical shares will generate the highest return on investment. By understating and applying Profound Medical stock analysis, traders can identify Profound Medical position entry and exit signals to maximize returns.

When running Profound Medical's price analysis, check to measure Profound Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Profound Medical is operating at the current time. Most of Profound Medical's value examination focuses on studying past and present price action to predict the probability of Profound Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Profound Medical's price. Additionally, you may evaluate how the addition of Profound Medical to your portfolios can decrease your overall portfolio volatility.